Foto del docente

Elisa Uliassi

Ricercatrice a tempo determinato tipo b) (senior)

Dipartimento di Farmacia e Biotecnologie

Settore scientifico disciplinare: CHIM/08 CHIMICA FARMACEUTICA

Pubblicazioni

Brevetto n. US10683277B2, Triazole derivatives as P2Y14 receptor antagonists.

Kiselev, Evgeny; Balasubramanian, Ramachandran; Uliassi, Elisa; Brown, Kyle A.; Trujillo, Kevin; Katritch, Vsevolod; Hammes, Eva; Stevens, Raymond C.; Harden, T. Kendall; Jacobson, Kenneth A., Design, synthesis, pharmacological characterization of a fluorescent agonist of the P2Y14 receptor, «BIOORGANIC & MEDICINAL CHEMISTRY LETTERS», 2015, 25, pp. 4733 - 4739 [articolo]

Santucci, Matteo; Vignudelli, Tatiana; Ferrari, Stefania; Mor, Marco; Scalvini, Laura; Bolognesi, Maria Laura; Uliassi, Elisa; Costi, Maria Paola, The Hippo Pathway and YAP/TAZ-TEAD Protein-Protein Interaction as Targets for Regenerative Medicine and Cancer Treatment, «JOURNAL OF MEDICINAL CHEMISTRY», 2015, 58, pp. 4857 - 4873 [articolo]

Brevetto n. U.S. Patent Application No. 62/233,162, TRIAZOLE DERIVATIVES AS P2Y14 RECEPTOR ANTAGONISTS.

Eugenie Nepovimova;Elisa Uliassi;Jan Korabecny;Luis Emiliano Peña-Altamira;Sarah Samez;Alessandro Pesaresi;Gregory E. Garcia;Manuela Bartolini;Vincenza Andrisano;Christian Bergamini;Romana Fato;Doriano Lamba;Marinella Roberti;Kamil Kuca;Barbara Monti;Maria Laura Bolognesi, Multitarget Drug Design Strategy: Quinone–Tacrine Hybrids Designed To Block Amyloid-β Aggregation and To Exert Anticholinesterase and Antioxidant Effects, «JOURNAL OF MEDICINAL CHEMISTRY», 2014, 57, pp. 8576 - 8589 [articolo]

Federica Belluti;Elisa Uliassi;Giacomo Veronesi;Christian Bergamini;Marcel Kaiser;Reto Brun;Angelo Viola;Romana Fato;Paul A. M. Michels;R. Luise Krauth-Siegel;Andrea Cavalli;Maria Laura Bolognesi, Toward the Development of Dual-Targeted Glyceraldehyde-3-phosphate Dehydrogenase/Trypanothione Reductase Inhibitors againstTrypanosoma bruceiandTrypanosoma cruzi, «CHEMMEDCHEM», 2014, 9, pp. 371 - 382 [articolo]

F. Prati;E. Uliassi;M. L. Bolognesi, Two diseases, one approach: multitarget drug discovery in Alzheimer's and neglected tropical diseases, «MEDCHEMCOMM», 2014, 5, pp. 853 - 861 [articolo]

Ultimi avvisi

Al momento non sono presenti avvisi.